Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pugh, G.
Right arrow Articles by Klaunig, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pugh, G., Jr.
Right arrow Articles by Klaunig, J. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 56, 181-188 (2000)
Copyright © 2000 by the Society of Toxicology

Effects of Di-isononyl Phthalate, Di-2-ethylhexyl Phthalate, and Clofibrate in Cynomolgus Monkeys

George Pugh, Jr.*, Jason S. Isenberg{dagger}, Lisa M. Kamendulis{dagger}, David C. Ackley{dagger}, Lisa J. Clare{ddagger}, Ray Brown§, Arthur W. Lington*,1, Jacqueline H. Smith* and James E. Klaunig{dagger},2

* Exxon Biomedical Sciences, Inc., East Millstone, New Jersey 08875; {dagger} Division of Toxicology, Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana 46202; {ddagger} T.P.S., Inc., Mount Vernon, Indiana 47620; and § Research Pathology Services, Inc., New Britain, Pennsylvania 18901

The effects of the peroxisome proliferators di-isononyl phthalate (DINP) and di-2-ethylhexyl phthalate (DEHP) were evaluated in young adult male cynomolgus monkeys after 14 days of treatment, with emphasis on detecting hepatic and other effects seen in rats and mice after treatment with high doses of phthalates. Groups of 4 monkeys received DINP (500 mg/kg/day), DEHP (500 mg/kg/day), or vehicle (0.5% methyl cellulose, 10 ml/kg) by intragastric intubation for 14 consecutive days. Clofibrate (250 mg/kg/day), a hypolipidemic drug used for cholesterol reduction in human patients was used as a reference substance. None of the test substances had any effect on body weight or liver weights. Histopathological examination of tissues from these animals revealed no distinctive treatment-related effects in the liver, kidney, or testes. There were also no changes in any of the hepatic markers for peroxisomal proliferation, including peroxisomal beta-oxidation (PBOX) or replicative DNA synthesis. Additionally, in situ dye transfer studies using fresh liver slices revealed that DINP, DEHP, and clofibrate had no effect on gap junctional intercellular communication (GJIC). None of the test substances produced any toxicologically important changes in urinalysis, hematology, or clinical chemistry; however, clofibrate produced some emesis, small increases in serum triglyceride, decreased calcium, and decreased weights of testes/epididymides and thyroid/parathyroid. The toxicological significance of these small changes is questionable. The absence of observable hepatic effects in monkeys at doses that produce hepatic effects in rodents suggests that DINP, DEHP, and clofibrate would also not elicit in primates other effects such as liver cancer. These data, along with results from in vitro hepatocyte studies, indicate that rodents are not good animal models for predicting the hepatic effects of phthalates in primates, including humans.

Key Words: tumor promotion; nongenotoxic carcinogens; phthalate esters; gap junctions; intercellular communication; hepatocytes; peroxisomes.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Phil Trans R Soc BHome page
C. E. Talsness, A. J. M. Andrade, S. N. Kuriyama, J. A. Taylor, and F. S. vom Saal
Components of plastic: experimental studies in animals and relevance for human health
Phil Trans R Soc B, July 27, 2009; 364(1526): 2079 - 2096.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. Ritter and T. E. Arbuckle
Can Exposure Characterization Explain Concurrence or Discordance between Toxicology and Epidemiology?
Toxicol. Sci., June 1, 2007; 97(2): 241 - 252.
[Abstract] [Full Text] [PDF]


Home page
International Journal of ToxicologyHome page
Annual Review of Cosmetic Ingredient Safety Assessments--2002/2003
International Journal of Toxicology, January 1, 2005; 24(1_suppl): 1 - 2.
[Full Text] [PDF]


Home page
Toxicol SciHome page
M. T. Bility, J. T. Thompson, R. H. McKee, R. M. David, J. H. Butala, J. P. Vanden Heuvel, and J. M. Peters
Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors (PPARs) by Phthalate Monoesters
Toxicol. Sci., November 1, 2004; 82(1): 170 - 182.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
R. C. Cattley
Peroxisome Proliferators and Receptor-Mediated Hepatic Carcinogenesis
Toxicol Pathol, February 1, 2004; 32(2_suppl): 6 - 11.
[Abstract] [PDF]


Home page
Jpn J Clin OncolHome page
H. Tsuda, A. Naito, C. K. Kim, K. Fukamachi, H. Nomoto, and M. A. Moore
Carcinogenesis and Its Modification by Environmental Endocrine Disruptors: In Vivo Experimental and Epidemiological Findings
Jpn. J. Clin. Oncol., June 1, 2003; 33(6): 259 - 270.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
K. A. Warner, M. J. Fernstrom, and R. J. Ruch
Inhibition of Mouse Hepatocyte Gap Junctional Intercellular Communication by Phenobarbital Correlates with Strain-Specific Hepatocarcinogenesis
Toxicol. Sci., February 1, 2003; 71(2): 190 - 197.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. Butenhoff, G. Costa, C. Elcombe, D. Farrar, K. Hansen, H. Iwai, R. Jung, G. Kennedy Jr., P. Lieder, G. Olsen, et al.
Toxicity of Ammonium Perfluorooctanoate in Male Cynomolgus Monkeys after Oral Dosing for 6 Months
Toxicol. Sci., September 1, 2002; 69(1): 244 - 257.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. M. Seacat, P. J. Thomford, K. J. Hansen, G. W. Olsen, M. T. Case, and J. L. Butenhoff
Subchronic Toxicity Studies on Perfluorooctanesulfonate Potassium Salt in Cynomolgus Monkeys
Toxicol. Sci., July 1, 2002; 68(1): 249 - 264.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. S. Isenberg, L. M. Kamendulis, D. C. Ackley, J. H. Smith, G. Pugh Jr., A. W. Lington, R. H. McKee, and J. E. Klaunig
Reversibility and Persistence of Di-2-ethylhexyl Phthalate (DEHP)- and Phenobarbital-Induced Hepatocellular Changes in Rodents
Toxicol. Sci., December 1, 2001; 64(2): 192 - 199.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
R. T. Miller, L. A. Scappino, S. M. Long, and J. C. Corton
Role of Thyroid Hormones in Hepatic Effects of Peroxisome Proliferators
Toxicol Pathol, January 1, 2001; 29(1): 149 - 155.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.